Id |
Subject |
Object |
Predicate |
Lexical cue |
T11 |
0-335 |
Sentence |
denotes |
Genetic variability across the three major histocompatibility complex (MHC) class I genes (human leukocyte antigen A [HLA-A], -B, and -C genes) may affect susceptibility to and severity of the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). |
T12 |
336-497 |
Sentence |
denotes |
We performed a comprehensive in silico analysis of viral peptide-MHC class I binding affinity across 145 HLA-A, -B, and -C genotypes for all SARS-CoV-2 peptides. |
T13 |
498-625 |
Sentence |
denotes |
We further explored the potential for cross-protective immunity conferred by prior exposure to four common human coronaviruses. |
T14 |
626-725 |
Sentence |
denotes |
The SARS-CoV-2 proteome was successfully sampled and was represented by a diversity of HLA alleles. |
T15 |
726-956 |
Sentence |
denotes |
However, we found that HLA-B*46:01 had the fewest predicted binding peptides for SARS-CoV-2, suggesting that individuals with this allele may be particularly vulnerable to COVID-19, as they were previously shown to be for SARS (M. |
T16 |
957-967 |
Sentence |
denotes |
Lin, H.-T. |
T17 |
968-977 |
Sentence |
denotes |
Tseng, J. |
T18 |
978-980 |
Sentence |
denotes |
A. |
T19 |
981-995 |
Sentence |
denotes |
Trejaut, H.-L. |
T20 |
996-1104 |
Sentence |
denotes |
Lee, et al., BMC Med Genet 4:9, 2003, https://bmcmedgenet.biomedcentral.com/articles/10.1186/1471-2350-4-9). |
T21 |
1105-1341 |
Sentence |
denotes |
Conversely, we found that HLA-B*15:03 showed the greatest capacity to present highly conserved SARS-CoV-2 peptides that are shared among common human coronaviruses, suggesting that it could enable cross-protective T-cell-based immunity. |
T22 |
1342-1481 |
Sentence |
denotes |
Finally, we reported global distributions of HLA types with potential epidemiological ramifications in the setting of the current pandemic. |